NextGen In Vitro Diagnostics is the company that is transforming the world of Infectious Disease Diagnostics through the use of technology to make diagnosis Accurate, Affordable, and Accessible to the majority of population.
Better Diagnostics, Better Healthcare.
Our mission is to enable affordable, easy and accurate diagnosis of infectious diseases to enable better healthcare for all.
Through the truly revolutionary technology of Multiplexing, it is now possible for NGIVD to replace the currently used time consuming, costly, and restrictive ‘Elimination’ approach of diagnostics with the more accurate, affordable, and accessible ‘Selection’ approach. With this technology and approach, it is now possible for syndromic identification. This means, many ailments can be screened with just a single sample and test to pin-point the exact problem; enabling medical practitioners to provide targeted treatments with shortened treatment times and faster recovery.
The NGIVD Value Proposition
Fevers of Unknown Origin
The multiplexing platform can be adopted to multiple disease areas, by changing the diagnostic assay (or test menu). These products will enable better diagnosis in even low-resource settings. In the last 4 years, NGIVD has developed a unique multiplex diagnostic test for detection of all forms of Tuberculosis, using blood as a sample, and is developing products for Kala Azar and fevers of unknown origin, making a difference in the lives of millions. With a strong portfolio of commercially selling products, and a rich pipeline of new products, NGIVD is on course to become a Rs 100 crore company in the next 3-4 years.
Biotechnology is an abiding passion for Mr Rupendra Singh. Things like Artificial Intelligence, e-commerce & Internet of Things (IoT) excite him.
Backed by 25 years of experience, Rupinder works on New Initiatives at NGIVD.
His interests include creating winning teams and lead them to generate next generation leadership.
Singh bagged a gold medal in MSc Biotech and has also completed his PhD (degree yet to be awarded).
K Sridharan, who is inspired by Infosys founder NR Narayana Murthy, loves to see himself as a change agent in NGIVD.
As Biosciences Products Head, he strives to build a next gen diagnostics enterprise with his contribution to the FNI segment with great products & strong customer profiles.
Building business, markets and creating the right customer mix are his focus areas. A science graduate with Chemistry as major, he has undergone professional training to hone his management skills.
He dreams of establishing a business of standalone nature and sees FNI as a great opportunity for NGIVD.
A multidimensional personality, Alok is committed to the environment & loves to understand the social and spiritual dimensions to life.
As Business Manager, Clinical Diagnostic, his vision is to make NGIVD, a full-fledged self-managed & profitable organization with its own range of products in different markets.
An M.Sc. in Chemistry, he has done his Post-graduate Diploma in Biochemical Technology. His areas of interests include scientific and concept selling with profitable and sustainable business growth.
His aim is to work as a professional entrepreneur and finds NGIVD to be the ideal platform to achieve his long-term goals.
Dr Puneet Gupta’s philosophy of life is to do something fruitful for the society rather than working for one’s own benefit. To achieve this, he is working on path-breaking diagnostic technologies for helping humankind with a larger outreach.
As Scientific Lead and Principal Investigator, he is focused on developing diagnostic platform/kits for detection of Mycobacterium tuberculosis, Leishmania, malaria, typhoid, dengue, chikungunya and Leptospirosis.
A PhD in Biotechnology, he has a vision to take NGIVD to be a major diagnostic solution provider across the globe. He has previously worked on developing malaria vaccines for both P. falciparum and P. vivax. He is highly inspired by his PhD supervisor Prof VS Chauhan.
Vikrant is a seasoned business development professional with more than 13 years of B2B experience in pharmaceutical, contract research and high-end diagnostics industry. He completed his Post graduation in Biotechnology in 2003. He also did one year of Training in clinical research under the flagship course named as YCPP.
Vikrant believes that NGIVD is evenly poised to harness the burgeoning market of POC diagnostic market by developing innovative, efficient and affordable diagnostic products which can cater to the requirements of patients at the bottom of the healthcare pyramid.
He has an excellent knack of building long-term working relationships with the clients.
Inspired by motivational guru Robin Sharma and powerful business leader Indira Nooyi, Anjali Agarwal is a finance professional with strong analytical skills and possesses an output-oriented attitude.
She contributes towards NGIVDs growth with maintenance of effective internal controls, adherence to all tax and legal compliances and leading the finance function.
In five years’ time, she wants to see NGIVD as company with all compliances in place and wants it to be an established player in the industry. After graduating in commerce (2009) from Delhi University, she completed her CA in 2011 (ICAI).
Anjali believes that striking a work-life balance is necessary for effective and productive functioning of all employees. She firmly believes that there is always scope for improvement and says the quest for excellence is a never-ending process.
The science and technology behind our solutions is proving its mettle both at home and abroad with grants from BIRAC (Biotechnology Innovation and Research Assistant Council, Department of Biotechnology) and accreditation from USISTEF (United States – India Science and Technology Endowment Fund).
BIRAC (Biotechnology Innovation and Research Assistant Council, a Department of Biotechnology) has awarded NGIVD’s TB diagnostic product with a Biotechnology Industry Partnership Program grant.
USISTEF (United States – India Science and Technology Endowment Fund) has also approved NGIVD’s TB diagnostic product.
Licensed the Leishmaniasis LAMP technology from ICMR (Indian Council of Medical Research)
Transforming the world of
Infectious Disease Diagnostics
scroll to explore